Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state in which AD has minimal impact on the patient’s life by achieving pre-agreed disease control goals through the use of an appropriate systemic therapy. Prof. Dr. med. Schmid-Grendelmeier gave a practice-oriented overview of the MDA concept in his presentation.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- HER2+ early breast cancer
DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines
- Lavender aromatherapy
Take away the fear of the dentist
- Digital dermatology: innovative project examples
AI and eHealth tools in HS care
- Mantle cell lymphoma
Recurrence after BTK inhibition – prognostic factors and treatment options
- Dementia risk with type 2 diabetes
SGLT2 inhibitors with advantages vs. DPP4 inhibitors
- T helper 1 cells
Differentiation and activation of Th1 cells – a multi-omics approach
- Cannabis for schizophrenia
CBD pre-treatment could exacerbate side effects
- Type 2 diabetes: cardiovascular risk reduction is realistic